AtriCure Inc
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
ATRC$56.26-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
YEARS ENDED DECEMBER 31, 2024, 2023, and 2022
(In Thousands)
| Common Stock · AdditionalPaid-inCapital · AccumulatedDeficit · AccumulatedOtherComprehensive(Loss) Income · TotalStockholders’Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||||||
| Balance—December 31, 2021 | 46,016 | $46 | $764,811 | $(280,153) | $(948) | $483,756 | |||||
| Issuance of common stock under equity incentive plans | 426 | 1 | (10,385) | — | — | (10,384) | |||||
| Issuance of common stock under employee stock purchase plan | 121 | — | 4,225 | — | — | 4,225 | |||||
| Share-based employee compensation expense | — | — | 28,771 | — | — | 28,771 | |||||
| Other comprehensive loss | — | — | — | — | (3,148) | (3,148) | |||||
| Net loss | — | — | — | (46,466) | — | (46,466) | |||||
| Balance—December 31, 2022 | 46,563 | $47 | $787,422 | $(326,619) | $(4,096) | $456,754 | |||||
| Issuance of common stock under equity incentive plans | 811 | 1 | (4,241) | — | — | (4,240) | |||||
| Issuance of common stock under employee stock purchase plan | 152 | — | 5,261 | — | — | 5,261 | |||||
| Share-based employee compensation expense | — | — | 35,728 | — | — | 35,728 | |||||
| Other comprehensive income | — | — | — | — | 3,103 | 3,103 | |||||
| Net loss | — | — | — | (30,438) | — | (30,438) | |||||
| Balance—December 31, 2023 | 47,526 | $48 | $824,170 | $(357,057) | $(993) | $466,168 | |||||
| Issuance of common stock under equity incentive plans | 1,080 | 1 | (5,929) | — | — | (5,928) | |||||
| Issuance of common stock under employee stock purchase plan | 263 | — | 5,064 | — | — | 5,064 | |||||
| Share-based employee compensation expense | — | — | 40,405 | — | — | 40,405 | |||||
| Other comprehensive loss | — | — | — | — | (42) | (42) | |||||
| Net loss | — | — | — | (44,698) | — | (44,698) | |||||
| Balance—December 31, 2024 | 48,869 | $49 | $863,710 | $(401,755) | $(1,035) | $460,969 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.